Drug Safety Assessment and the MID-NET® (Japanese Medical Information Database Network)

Yamaguchi, Mitsune; Takahashi, Fumitaka; Uyama, Yoshiaki

doi:10.1007/978-981-16-6376-5_7

SpringerBriefs for Data Scientists and Innovators

2022

DOI: 10.1007/978-981-16-6376-5_7

|View full text |Cite

Drug Safety Assessment and the MID-NET® (Japanese Medical Information Database Network)

Mitsune Yamaguchi

Fumitaka Takahashi

Yoshiaki Uyama

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe

Yang¹,

Kim²,

Park³

2023

J Health Info Stat

View full text Add to dashboard Cite

Objectives: With the growing interest in big data, regulatory agencies in United States, Japan, and Europe are showing active movements to use RWD and RWE to manage drug safety and development activation. Along with the global movements, it is necessary to establish a basic system for utilizing RWD based drug lifecycle data for drug safety management in Korea. The purpose of this study is to review and find implication of the collection and utilization of drug lifecycle data in the U.S., Japan, and Europe.Methods: In order to investigate the current status and contents of each country’s system, we searched the websites of each country’s regulatory agency and related agencies, and collected and investigated related laws, papers, and reports. We compared and analyzed focusing on solving regulatory problems that may occur in the drug lifecycle or exploring the safety and potential effects of drugs in drug lifecycle phases.Results: Based on FDA Sentinel 5-year plan and MID-NET, the U.S. and Japan are accelerating the generation of real data and real evidence for regulatory decision-making in post-marketing safety management. In Europe, various clinical field-specific projects have been undertaken to assess the effectiveness and safety of drugs due to disease. Various research cases using drug lifecycle data collected from drug safety management systems in each country have been represented.Conclusions: By identifying drug safety management systems and cases of drug lifecycle data utilization in various countries, we expect to serve as a stepping stone for discussions on the direction and utilization plan to efficiently develop drug safety management systems in Korea.

show abstract

Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe

Yang¹,

Kim²,

Park³

2023

J Health Info Stat

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Drug Safety Assessment and the MID-NET® (Japanese Medical Information Database Network)

Cited by 1 publication

References 20 publications

Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe

Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe

Contact Info

Product

Resources

About